91 related articles for article (PubMed ID: 21447733)
1. Use of transporter knockdown Caco-2 cells to investigate the in vitro efflux of statin drugs.
Li J; Volpe DA; Wang Y; Zhang W; Bode C; Owen A; Hidalgo IJ
Drug Metab Dispos; 2011 Jul; 39(7):1196-202. PubMed ID: 21447733
[TBL] [Abstract][Full Text] [Related]
2. Silencing the breast cancer resistance protein expression and function in caco-2 cells using lentiviral vector-based short hairpin RNA.
Zhang W; Li J; Allen SM; Weiskircher EA; Huang Y; George RA; Fong RG; Owen A; Hidalgo IJ
Drug Metab Dispos; 2009 Apr; 37(4):737-44. PubMed ID: 19131524
[TBL] [Abstract][Full Text] [Related]
3. Comparative Hepatic and Intestinal Efflux Transport of Statins.
Deng F; Tuomi SK; Neuvonen M; Hirvensalo P; Kulju S; Wenzel C; Oswald S; Filppula AM; Niemi M
Drug Metab Dispos; 2021 Sep; 49(9):750-759. PubMed ID: 34162690
[TBL] [Abstract][Full Text] [Related]
4. Differential interaction of 3-hydroxy-3-methylglutaryl-coa reductase inhibitors with ABCB1, ABCC2, and OATP1B1.
Chen C; Mireles RJ; Campbell SD; Lin J; Mills JB; Xu JJ; Smolarek TA
Drug Metab Dispos; 2005 Apr; 33(4):537-46. PubMed ID: 15616150
[TBL] [Abstract][Full Text] [Related]
5. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
6. Atorvastatin transport in the Caco-2 cell model: contributions of P-glycoprotein and the proton-monocarboxylic acid co-transporter.
Wu X; Whitfield LR; Stewart BH
Pharm Res; 2000 Feb; 17(2):209-15. PubMed ID: 10751037
[TBL] [Abstract][Full Text] [Related]
7. Coupling of UDP-glucuronosyltransferases and multidrug resistance-associated proteins is responsible for the intestinal disposition and poor bioavailability of emodin.
Liu W; Feng Q; Li Y; Ye L; Hu M; Liu Z
Toxicol Appl Pharmacol; 2012 Dec; 265(3):316-24. PubMed ID: 22982073
[TBL] [Abstract][Full Text] [Related]
8. Role of P-glycoprotein in statin drug interactions.
Holtzman CW; Wiggins BS; Spinler SA
Pharmacotherapy; 2006 Nov; 26(11):1601-7. PubMed ID: 17064205
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the involvement of P-glycoprotein and multidrug resistance-associated protein 2 in the efflux of ximelagatran and its metabolites by using short hairpin RNA knockdown in Caco-2 cells.
Darnell M; Karlsson JE; Owen A; Hidalgo IJ; Li J; Zhang W; Andersson TB
Drug Metab Dispos; 2010 Mar; 38(3):491-7. PubMed ID: 20023051
[TBL] [Abstract][Full Text] [Related]
10. Transport of hop bitter acids across intestinal Caco-2 cell monolayers.
Cattoor K; Bracke M; Deforce D; De Keukeleire D; Heyerick A
J Agric Food Chem; 2010 Apr; 58(7):4132-40. PubMed ID: 20329731
[TBL] [Abstract][Full Text] [Related]
11. Stable suppression of MDR1 gene expression and function by RNAi in Caco-2 cells.
Celius T; Garberg P; Lundgren B
Biochem Biophys Res Commun; 2004 Nov; 324(1):365-71. PubMed ID: 15465028
[TBL] [Abstract][Full Text] [Related]
12. Comparison of drug transporter gene expression and functionality in Caco-2 cells from 10 different laboratories.
Hayeshi R; Hilgendorf C; Artursson P; Augustijns P; Brodin B; Dehertogh P; Fisher K; Fossati L; Hovenkamp E; Korjamo T; Masungi C; Maubon N; Mols R; Müllertz A; Mönkkönen J; O'Driscoll C; Oppers-Tiemissen HM; Ragnarsson EG; Rooseboom M; Ungell AL
Eur J Pharm Sci; 2008 Dec; 35(5):383-96. PubMed ID: 18782614
[TBL] [Abstract][Full Text] [Related]
13. [Absorption of coptisine chloride and berberrubine across human intestinal epithelial by using human Caco-2 cell monolayers].
Ma L; Yang XW
Zhongguo Zhong Yao Za Zhi; 2007 Dec; 32(23):2523-7. PubMed ID: 18330249
[TBL] [Abstract][Full Text] [Related]
14. Effect of benzo[a]pyrene on P-glycoprotein-mediated transport in Caco-2 cell monolayer.
Sugihara N; Toyama K; Michihara A; Akasaki K; Tsuji H; Furuno K
Toxicology; 2006 Jun; 223(1-2):156-65. PubMed ID: 16647797
[TBL] [Abstract][Full Text] [Related]
15. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
[TBL] [Abstract][Full Text] [Related]
16. Biliary efflux transporters involved in the clearance of rosuvastatin in sandwich culture of primary rat hepatocytes.
Jemnitz K; Veres Z; Tugyi R; Vereczkey L
Toxicol In Vitro; 2010 Mar; 24(2):605-10. PubMed ID: 19853032
[TBL] [Abstract][Full Text] [Related]
17. Stereoselective and multiple carrier-mediated transport of cetirizine across Caco-2 cell monolayers with potential drug interaction.
He Y; Liu Y; Zeng S
Chirality; 2010 Jul; 22(7):684-92. PubMed ID: 20014242
[TBL] [Abstract][Full Text] [Related]
18. P-glycoprotein-mediated transport of oxytetracycline in the Caco-2 cell model.
Schrickx J; Fink-Gremmels J
J Vet Pharmacol Ther; 2007 Feb; 30(1):25-31. PubMed ID: 17217397
[TBL] [Abstract][Full Text] [Related]
19. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
[TBL] [Abstract][Full Text] [Related]
20. Identification of interspecies difference in efflux transporters of hepatocytes from dog, rat, monkey and human.
Li M; Yuan H; Li N; Song G; Zheng Y; Baratta M; Hua F; Thurston A; Wang J; Lai Y
Eur J Pharm Sci; 2008 Sep; 35(1-2):114-26. PubMed ID: 18639632
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]